JPH01273595A - Production of gamma-halo-beta-hydroxybutyric acid ester - Google Patents
Production of gamma-halo-beta-hydroxybutyric acid esterInfo
- Publication number
- JPH01273595A JPH01273595A JP10138088A JP10138088A JPH01273595A JP H01273595 A JPH01273595 A JP H01273595A JP 10138088 A JP10138088 A JP 10138088A JP 10138088 A JP10138088 A JP 10138088A JP H01273595 A JPH01273595 A JP H01273595A
- Authority
- JP
- Japan
- Prior art keywords
- acid ester
- gamma
- halo
- culture
- hydroxybutyric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 150000002148 esters Chemical class 0.000 claims abstract description 12
- 241000223218 Fusarium Species 0.000 claims abstract description 5
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 claims abstract description 5
- 241001619326 Cephalosporium Species 0.000 claims abstract description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000221566 Ustilago Species 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims description 13
- 241000233866 Fungi Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000002538 fungal effect Effects 0.000 abstract 2
- 241000082085 Verticillium <Phyllachorales> Species 0.000 abstract 1
- 239000003905 agrochemical Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 244000005700 microbiome Species 0.000 description 10
- -1 hydroxybutyric acid ester Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- OOTHJWKSGHCRRW-UHFFFAOYSA-N 2-chloro-2-ethyl-3-hydroxybutanoic acid Chemical compound CCC(C(C)O)(C(=O)O)Cl OOTHJWKSGHCRRW-UHFFFAOYSA-N 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000221778 Fusarium fujikuroi Species 0.000 description 1
- 241000577840 Fusarium merismoides Species 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 244000301083 Ustilago maydis Species 0.000 description 1
- 235000015919 Ustilago maydis Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- HFLMYYLFSNEOOT-UHFFFAOYSA-N methyl 4-chloro-3-oxobutanoate Chemical compound COC(=O)CC(=O)CCl HFLMYYLFSNEOOT-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はT−ハロアセト酢酸エステルに糸状菌を作用さ
せて、γ−ハロ−β−ヒドロキシ酪酸エステルを製造す
る方法に関する。γ−ハロ−β−ヒドロキシ酪酸エステ
ルは農医薬合成原料として有用である。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for producing γ-halo-β-hydroxybutyric acid ester by allowing filamentous fungi to act on T-haloacetoacetic ester. γ-halo-β-hydroxybutyric acid ester is useful as a raw material for agricultural and pharmaceutical synthesis.
〔従来の技術及び発明が解決しようとする課題〕T−ハ
ロアセト酢酸エステルを化学的に還元して対応するγ−
ハロ−β−ヒドロキシ酪酸エステルを製造する場合、副
反応が起こりやすく、目的物の収率が低いという欠点が
ある。そこでこれらを解決するために、L−β−ヒドロ
キシアシルCo^デヒドロゲナーゼを産生ずる微生物の
発酵酵素作用を利用する方法(特開昭59−11809
3号公帳)が提案された。しかし、報告されている微生
物は酵素活性等実用上問題点があり、里に、有利な微生
物を利用する方法の確立が求められている。[Problems to be solved by the prior art and the invention] Chemically reducing T-haloacetoacetate to obtain the corresponding γ-
When producing halo-β-hydroxybutyric acid ester, there are disadvantages in that side reactions are likely to occur and the yield of the target product is low. Therefore, in order to solve these problems, a method using the fermentation enzyme action of microorganisms that produce L-β-hydroxyacyl Co^ dehydrogenase (Japanese Patent Application Laid-Open No. 11809-1989) was proposed.
Public Book No. 3) was proposed. However, the reported microorganisms have practical problems such as enzyme activity, and there is a need to establish a method to utilize advantageous microorganisms.
本発明は、γ−ハロアセト酢酸エステルを対応するT−
へローβ−ヒドロキシ酪酸エステルに変換する能力を有
するセファロスポリウム(Cephalosporiu
m)属、パエシロマイセス(Paecilon+yce
s)属、ハーティシラム(Verticillum)属
、フザリウム(Fusarium)属、ウスチラゴ(U
sttlago)属及びジベレラ(Gihberell
a)属の糸状菌より選らばれた1種の培養物、菌体、又
は菌体処理物をT−ハロアセト酢酸エステルに作用させ
、生成物を採取することを特徴とするγ−ハロ−β−ヒ
ドロキシ酪酸エステルの製造法である。The present invention converts the γ-haloacetoacetate into the corresponding T-
Cephalosporium has the ability to convert to helo-β-hydroxybutyrate.
m) Genus, Paecilomyces (Paecilon+yce)
s), Verticillum spp., Fusarium spp., Ustilago spp.
sttlago) and Gihberella
a) γ-halo-β-, which is characterized in that one type of culture, bacterial cells, or treated bacterial cells selected from filamentous fungi of the genus is allowed to act on T-haloacetoacetic acid ester, and the product is collected. This is a method for producing hydroxybutyric acid ester.
本発明で用いるT−ハロアセト酢酸エステルは、一般式
’R+−CH□CO・CH2C00RZ(式中R1はハ
ロゲンであり、
R2はアルキル基、フェニル基、アリール基等の任意の
有機残基である)
で示される化合物である。The T-haloacetoacetic acid ester used in the present invention has the general formula 'R+-CH□CO・CH2C00RZ (in the formula, R1 is a halogen, and R2 is an arbitrary organic residue such as an alkyl group, a phenyl group, an aryl group, etc.) This is a compound represented by
本発明で用いるT−ハロアセト酢酸エステルは、例えば
有機溶媒でハロゲンとジケテンを反応させることにより
得られるが、必要ならT−ハロアセト酢酸エステルから
通常のグリニヤール反応によっても製造することができ
る。The T-haloacetoacetate used in the present invention can be obtained, for example, by reacting a halogen and diketene in an organic solvent, but if necessary, it can also be produced from the T-haloacetoacetate by a conventional Grignard reaction.
本発明で用いる微生物は、T−ハロアセト酢酸エステル
を対応するγ−ハロ−β−ヒドロキシ酪酸エステルに変
換する能力を有する糸状菌の一種であり、例えば、セフ
ァロスポリウム チャーティコラ(Cephalosp
orium charticola) IFO8952
、パエシロマイセス エレガンス(Paec i lo
mycesele3ans) IFo 6987 、ウ
スチラゴ ゼアエ(Ustilago Zeae) I
FO5346、パーティシリウムニベオストラトサム(
VerticilliumniveosLratosu
m) IPO6625、ジベレラ フジクロイ (Gi
bberella fujikuroi) IFO63
49、フザリウム メリスモイデス (Fusariu
m merismoides)IFO30040が好適
に用いられる。The microorganism used in the present invention is a type of filamentous fungus that has the ability to convert T-haloacetoacetate to the corresponding γ-halo-β-hydroxybutyrate.
orium charticola) IFO8952
, Paecilomyces elegans
mycesele3ans) IFo 6987, Ustilago Zeae I
FO5346, Particillium niveostratosum (
VerticilliumniveosLratosu
m) IPO6625, Gibberella fujikuroi (Gi
bberella fujikuroi) IFO63
49, Fusarium merismoides (Fusariu
m merismoides) IFO30040 is preferably used.
上記の微生物は一般的性質として自然あるいは人工的手
段により変異を起し得るが、T−ハロアセト酢酸エステ
ルを還元してγ−ハロ−β−ヒドロキシ酪酸エステルに
変換するものすべて本発明の製造法に利用し得る。Although the above-mentioned microorganisms can generally undergo mutation by natural or artificial means, all microorganisms that reduce T-haloacetoacetate and convert it into γ-halo-β-hydroxybutyrate can be used in the production method of the present invention. It can be used.
本発明で用いる微生物は常法に従って培養することがで
きる。培養に用いられる培地は生育に必要な尿素源、窒
素源、無機物質等を含む通常の培地である。更にビタミ
ン、アミノ酸等の有機mW栄養素を添加すると望ましい
結果が得られる場合が多い。The microorganisms used in the present invention can be cultured according to conventional methods. The medium used for culture is a normal medium containing a urea source, a nitrogen source, inorganic substances, etc. necessary for growth. Furthermore, desirable results are often obtained by adding organic mW nutrients such as vitamins and amino acids.
培養は好気的条件下にpH3〜8、温度10〜40℃の
適当な範囲に制御しつつ1〜10日間培養を行う。反応
にあたっては、培養液又は培養液から分解採取した培養
菌体などいずれも使用できる。The culture is carried out under aerobic conditions for 1 to 10 days while controlling the pH to 3 to 8 and the temperature to an appropriate range of 10 to 40°C. In the reaction, either a culture solution or cultured bacterial cells decomposed and collected from the culture solution can be used.
また菌体処理物として、凍結乾燥やアセトン乾燥などの
方法で得た乾燥菌体、菌体や磨砕あるいは自己消化、超
音波処理などの方法で得た菌体破砕液のほか、T−ハロ
アセト酢酸エステルを対応するγ−ハロ−β−ヒドロキ
シ酪酸エステルに変換する酵素活性を有する酵素タンパ
ク区分、更にはこれら菌体または菌体処理物の固定化物
、その他いずれも使用できる。In addition, the bacterial cell treatment products include dried bacterial cells obtained by freeze-drying, acetone drying, etc., bacterial cell suspension obtained by grinding, autolysis, ultrasonication, etc., as well as T-haloacetate Enzyme protein fractions having enzymatic activity for converting acetate esters into the corresponding γ-halo-β-hydroxybutyric esters, immobilized products of these microbial cells or processed products of the microbial cells, and any others can be used.
T−ハロアセト酢酸エステルを対応するγ−ハロ−β−
ヒドロキシ酪酸エステルに変換する方法は、水性媒体中
にてT−ハロアセト酢酸エステルと上記微生物の培養液
、菌体、菌体処理物あるいはこれらを公知の方法で固定
化したものと接触させれば良い。T-haloacetoacetate corresponding to γ-halo-β-
The conversion to hydroxybutyric acid ester can be carried out by contacting T-haloacetoacetic ester with a culture solution, bacterial cells, treated bacterial cells, or a product obtained by immobilizing these by a known method in an aqueous medium. .
かかる反応時の水性媒体としては、水、緩衝液および含
水有機溶媒が使用できる。As the aqueous medium during such a reaction, water, a buffer solution, and a water-containing organic solvent can be used.
上記微生物をγ−ハロアセト酢酸エステルに作用させる
には、通常、pHを3〜8、反応温度を10〜60″C
の範囲に制御しつつ行なう。In order to allow the above microorganisms to act on γ-haloacetoacetate, the pH is usually 3 to 8 and the reaction temperature is 10 to 60"C.
Do this in a controlled manner.
反応系に対してT−ハロアセト酢酸エステルはそのまま
、あるいは溶媒に溶解するか、あるいは分散させて添加
する。The T-haloacetoacetate is added to the reaction system as it is, dissolved in a solvent, or dispersed.
反応系のエステル濃度は通常0.001〜50重量%の
範囲が良い。かかるT−ハロアセト酢酸エステルの添加
は反応の任意の段階で可能であり、−括、連続、分割の
いずれの手段でも実施できる。The ester concentration in the reaction system is usually preferably in the range of 0.001 to 50% by weight. The T-haloacetoacetic acid ester can be added at any stage of the reaction, and can be carried out collectively, continuously, or in portions.
反応時にグルコース等の糖類や、微生物の栄養素、界面
活性剤等を共存させて反応を行なうこともできる。反応
時間は、濃度等条件により調整できるが、長(とも48
時間程度を行なえば、γ−ハロアセト11エステル・は
対応するγ−ハロ−β−ヒドロキシ酪酸エステルに変換
される。The reaction can also be carried out in the presence of sugars such as glucose, nutrients for microorganisms, surfactants, and the like. The reaction time can be adjusted depending on conditions such as concentration, but it is long (total
Over a period of time, the γ-haloaceto 11 ester is converted to the corresponding γ-halo-β-hydroxybutyric acid ester.
このようにして得られたγ−ハロ−β−ヒドロキシ酪酸
エステルを培養液又は反応液より採取するには、菌体又
は菌体処理物を遠心分離や限外濾過等の常法に従って除
去し、エーテル、四塩化炭素、ヘンゼン、酢酸エチル等
の有機溶媒を用いて抽出する方法等の通常の方法を採用
することができる。In order to collect the γ-halo-β-hydroxybutyric acid ester obtained in this way from the culture solution or reaction solution, the bacterial cells or the treated bacterial cells are removed by a conventional method such as centrifugation or ultrafiltration. Conventional methods such as extraction using an organic solvent such as ether, carbon tetrachloride, Hensen, ethyl acetate, etc. can be employed.
次に、実施例によって本発明の方法を更に詳しく説明す
る。Next, the method of the present invention will be explained in more detail by way of examples.
実施例1
グルコース5重量%、コーン・ステイープ・リカー5重
世%からなる培地(pH6,5) 5 m!!を試験管
に取り、表1に示した微生物を接種して28℃で48時
間、振とう培養を行った。Example 1 Medium (pH 6.5) consisting of 5% glucose by weight and 5% corn steep liquor (pH 6.5) 5 m! ! was placed in a test tube, inoculated with the microorganisms shown in Table 1, and cultured with shaking at 28°C for 48 hours.
この系にγ−クロロアセト酢酸メチル25μlを添加し
、さらに24時間振とう培養を続は反応を行なった。To this system, 25 μl of methyl γ-chloroacetoacetate was added, followed by shaking culture for 24 hours, followed by reaction.
得られた反応液を遠心分離で除菌処理した後、反応液2
mlを酢酸エチル4 mlで抽出し、ガスクロマトグ
ラフィー(品性GC−9APF XPEG 20Mx1
m、150℃、Nz30mj!/分)で分析した。結果
を表1に示す。After the obtained reaction solution was sterilized by centrifugation, reaction solution 2
ml was extracted with 4 ml of ethyl acetate, and subjected to gas chromatography (GC-9APF
m, 150℃, Nz30mj! /min). The results are shown in Table 1.
実施例?
γ−クロロアセト酢酸エチルを基質に用いて実施例1と
同様に反応を行い、分析した。結果を表1に示す。Example? A reaction was carried out and analyzed in the same manner as in Example 1 using ethyl γ-chloroacetoacetate as a substrate. The results are shown in Table 1.
実施例3
グルコース5重量%、コーン・ステイープリカー5重量
%からなる培地(ρl+6.5) 5 mlを試験管に
取り、パエシロマイセス エレガンスIF06987を
接種して28℃で24時間振とう培養を行ない種培養液
を得た。Example 3 5 ml of a medium (ρl+6.5) consisting of 5% by weight of glucose and 5% by weight of corn staple liquor was placed in a test tube, inoculated with Paecilomyces elegans IF06987, and cultured with shaking at 28° C. for 24 hours. A culture solution was obtained.
次に上記と同一組成の培地100+nlを500me容
坂ロフラスコに取り、種培養液5IIllを添加して2
8°Cで振とう培養を行なった。Next, 100+nl of a medium with the same composition as above was placed in a 500me capacity Sakaro flask, and 5IIll of seed culture solution was added.
Shaking culture was performed at 8°C.
得られた培養液を遠心分離し、0.9%NaC(!水で
洗浄したのち、l (w/v)%のグルコースを含む
0.1Mリン酸緩衝液(pH6,0) 100 ml
!に懸濁し、T−クロロアセト酢酸エチル1.0gを添
加し、通気、振とうしながら18時間反応を行なった。The obtained culture solution was centrifuged, washed with 0.9% NaC (! water, and then mixed with 100 ml of 0.1 M phosphate buffer (pH 6,0) containing l (w/v)% glucose.
! 1.0 g of ethyl T-chloroacetoacetate was added thereto, and the reaction was carried out for 18 hours with ventilation and shaking.
得られた反応液を遠心分離で除菌処理した後、酢酸エチ
ル300 ml! (100ml×3回)で抽出を行な
った。この酢酸エチル層に無水硫酸マグネシウムを添加
、脱水したのち、減圧濃縮して0、98 gの油状生成
物を得た。このものを減圧蒸留してIR(島IIR−4
35)、NMR(日本電子PMX60SI)、ガスクロ
マ(・グラフィー(品性GC−9^PFXPEG 20
Mx 1m、 150℃、Nz 30 ml /min
)で確認したところ、γ−クロローβ−ヒドロキシ酪
酸エチルであることを確認した。After sterilizing the resulting reaction solution by centrifugation, 300 ml of ethyl acetate was added. Extraction was performed using (100 ml x 3 times). Anhydrous magnesium sulfate was added to this ethyl acetate layer to dehydrate it, followed by concentration under reduced pressure to obtain 0.98 g of an oily product. This product was distilled under reduced pressure and IR (Island IIR-4
35), NMR (JEOL PMX60SI), gas chromatography (quality GC-9^PFXPEG 20
Mx 1m, 150℃, Nz 30ml/min
), it was confirmed that it was ethyl γ-chloroβ-hydroxybutyrate.
NMR
δ(CDC1、中):δ(ppm)
1.25 (30,t) 、2.60 (2H,d
)、3.35 (L H,s、 exthangea
ble 、 OH)3.60 (2H,d) 、4.
2 (2H,q)C
R・T(分)4.6
実施例4
γ−クロロアセト酢酸オクチルを基質に用いて、実施例
3と同様にして反応を行ない、ガスクロマトグラフィー
(品性GC−9APF、 0V−1x 1m、125°
c、Nz 30 ml/分)、IR(品性IR−435
) 、NMR(JEOLGX−270) ”liI認し
たところ、T−クロロ−β−ヒドロキシ酪酸オクチルで
あることを確認した。また、反応収率は75%であった
。NMR δ (CDC1, medium): δ (ppm) 1.25 (30, t), 2.60 (2H, d
), 3.35 (L H,s, exchangea
ble, OH) 3.60 (2H, d), 4.
2 (2H,q)C R・T (min) 4.6 Example 4 Using octyl γ-chloroacetoacetate as a substrate, the reaction was carried out in the same manner as in Example 3. , 0V-1x 1m, 125°
c, Nz 30 ml/min), IR (quality IR-435
), NMR (JEOLGX-270) ``liI'' confirmed that it was octyl T-chloro-β-hydroxybutyrate.The reaction yield was 75%.
尚、基質は1 mlの10%Tween80 (KAO
−ATLAS)で乳化して反応系に添加した。The substrate was 1 ml of 10% Tween 80 (KAO
-ATLAS) and added to the reaction system.
実施例5
実施例3と同様にして得た湿菌体10gを20m1の0
.1 Mリン酸緩衝液(pl+ 6.5 )にけん濁し
、氷水で冷却しながら5分間の超音波処理を4回行い、
遠心分離で不溶物を除去することにより、粗酵素液を得
た。Example 5 10 g of wet bacterial cells obtained in the same manner as in Example 3 was added to 20 ml of
.. Suspend in 1 M phosphate buffer (pl + 6.5), perform 5-minute ultrasonic treatment 4 times while cooling with ice water,
A crude enzyme solution was obtained by removing insoluble matter by centrifugation.
この粗酵素液10m1にNADPI+ (シグマ社)2
00実施例3と同様にして反応液を分析したところ、T
−クロロ−β−ヒドロキシ酪酸エチルの収率は95%で
あった。Add 2 NADPI+ (Sigma) to 10ml of this crude enzyme solution.
00 When the reaction solution was analyzed in the same manner as in Example 3, T
The yield of ethyl -chloro-β-hydroxybutyrate was 95%.
本発明によればT−ハロアセト酢酸エステルからγ−ハ
ロ−β−ヒドロキシ酪酸エステルを高収率で得ることが
でき、工業的に有利である。According to the present invention, γ-halo-β-hydroxybutyric acid ester can be obtained from T-haloacetoacetic ester in high yield, which is industrially advantageous.
特許出願人 電気化学工業株式会社Patent applicant: Denki Kagaku Kogyo Co., Ltd.
Claims (1)
−β−ヒドロキシ酪酸エステルに変換する能力を有する
セファロスポリウム (Cephalosporium)属、パエシロマイセ
ス(Paecilomyces)属、バーティシラム(
Verticillum)属、フザリウム(Fusar
ium)属、ウスチラゴ(Ustilago)属及びジ
ベレラ(Gibberella)属の糸状菌より選らば
れた1種の培養物、菌体、又は菌体処理物をγ−ハロア
セト酢酸エステルに作用させ、生成物を採取することを
特徴とするγ−ハロ−β−ヒドロキシ酪酸エステルの製
造法。(1) The genus Cephalosporium, the genus Paecilomyces, and the genus Verticillum (
Genus Verticillum, Fusarium
One type of culture, bacterial cells, or treated bacterial cells selected from filamentous fungi of the genus Ium, Ustilago, and Gibberella is allowed to act on γ-haloacetoacetic ester, and the product is collected. A method for producing γ-halo-β-hydroxybutyric acid ester.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10138088A JP2624296B2 (en) | 1988-04-26 | 1988-04-26 | Method for producing γ-halo-β-hydroxybutyrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10138088A JP2624296B2 (en) | 1988-04-26 | 1988-04-26 | Method for producing γ-halo-β-hydroxybutyrate |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01273595A true JPH01273595A (en) | 1989-11-01 |
JP2624296B2 JP2624296B2 (en) | 1997-06-25 |
Family
ID=14299179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10138088A Expired - Lifetime JP2624296B2 (en) | 1988-04-26 | 1988-04-26 | Method for producing γ-halo-β-hydroxybutyrate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2624296B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10508599A (en) * | 1994-11-07 | 1998-08-25 | ミネソタ・マイニング・アンド・マニュファクチュアリング・カンパニー | Purification of stable organic compounds |
-
1988
- 1988-04-26 JP JP10138088A patent/JP2624296B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10508599A (en) * | 1994-11-07 | 1998-08-25 | ミネソタ・マイニング・アンド・マニュファクチュアリング・カンパニー | Purification of stable organic compounds |
Also Published As
Publication number | Publication date |
---|---|
JP2624296B2 (en) | 1997-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06209782A (en) | Production of optically active 4-halo-3-hydroxybutyric acid ester | |
US5128261A (en) | Natural delta-lactones and process of the production thereof | |
US3956337A (en) | Process for the preparation of D-gluconic-δ-lactam | |
JPH01273595A (en) | Production of gamma-halo-beta-hydroxybutyric acid ester | |
Tramper et al. | Xanthine oxidase activity of arthrobacter x-4 cells immobilized in glutaraldehyde-crosslinked gelatin | |
JPH01168292A (en) | Production of d-glyceric acid | |
EP0365029B1 (en) | Method of systhesizing optically active beta-halolactic acid or glycidic acid | |
JP3030916B2 (en) | Method for producing β-glucooligosaccharide | |
JPH0231684A (en) | Production of optically active 1,3-butanediol | |
JP3740205B2 (en) | Production method of (R) -2-alkanol | |
JPH0585160B2 (en) | ||
JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
JP3917723B2 (en) | Lactone hydrolase and process for producing the same | |
JPH01222798A (en) | Production of optically active carboxylic acid and antipode ester thereof | |
JP2828720B2 (en) | Method for producing optically active 1,3-butanediol | |
JPS6012993A (en) | Production of optically active carboxylic acid | |
JPS63105684A (en) | Production of (r)-gamma-azido-beta-hydroxybutyric acid ester | |
JPS6359678B2 (en) | ||
JPWO2004048586A1 (en) | Process for producing optically active 1-cyclohexyl-2-propyn-1-ol | |
JPH04316489A (en) | Production of optically active (s)-3-chloro-1-phenyl-1-propanol | |
JPH04252189A (en) | Production of benzenedicarboxlic monoester or derivative thereof | |
JPS61242585A (en) | Production of gamma-halogenated-beta-hydroxybutyric acid | |
JPH04152896A (en) | Production of optically active 3-phenyl-1,3-propanediol | |
JPH0553476B2 (en) | ||
JPH02227074A (en) | Production of new exo-type hydrolase and inulotriose and/or inulotetraose |